![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/18/2900365/33039/en/ProQR-Announces-Presentation-on-its-Axiomer-RNA-Editing-Technology-at-RNA-Editing-Summit.html
https://www.globenewswire.com/news-release/2024/05/09/2878573/33039/en/ProQR-Announces-First-Quarter-2024-Operating-and-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/08/2877783/33039/en/ProQR-Announces-Preclinical-Proof-of-Concept-Data-for-AX-0810-Axiomer-RNA-Editing-Program-Targeting-NTCP-for-Cholestatic-Diseases.html
https://www.globenewswire.com/news-release/2024/04/23/2867495/33039/en/ProQR-Nominates-Martin-Maier-PhD-to-Board-and-Announces-Annual-Meeting-of-Shareholders-to-be-Held-May-22-2024.html
https://www.globenewswire.com/news-release/2024/04/22/2867245/33039/en/ProQR-Highlights-Upcoming-Presentations-on-Axiomer-RNA-Editing-at-ASGCT-27th-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/19/2866078/33039/en/ProQR-Achieves-Successful-Defense-of-New-Challenge-to-its-Axiomer-IP-Portfolio.html
https://www.globenewswire.com//news-release/2024/03/13/2845299/33039/en/ProQR-Announces-Year-End-2023-Operating-and-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/15/2829825/33039/en/ProQR-Announces-Japanese-Axiomer-Patent-Upheld-Following-Opposition-Against-Its-Leading-IP-Estate-for-ADAR-mediated-RNA-Editing.html
https://www.globenewswire.com//news-release/2024/01/19/2812237/33039/en/ProQR-Highlights-New-Platform-Data-from-Presentation-on-Axiomer-RNA-Editing-Technology-at-Deaminet-2024.html
https://www.globenewswire.com//news-release/2024/01/05/2804566/33039/en/ProQR-and-Rett-Syndrome-Research-Trust-Join-Forces-with-Axiomer-RNA-Editing-Collaboration.html